H_MRGPRX2 Gq Reporter CHO-K1 Cell Line
Cat. No.
GM-C44540
Size
1 vial
Quote
Description
Data Display
Specifications
Materials
Cell Culture
Related products
Description
MRGPRX2 (Mas-related G protein-coupled receptor member X2) is a G protein-coupled receptor (GPCR) primarily expressed in mast cells and certain neural tissues. The MRGPRX2 receptor is involved in various physiological and pathological processes, including pain transmission, immune responses, and inflammatory reactions. It can recognize and bind to a variety of ligands, including cyclic peptides and pro-inflammatory molecules. MRGPRX2 is associated with certain allergic diseases, such as chronic urticaria and anaphylactic shock, as its expression in mast cells can trigger the release of histamine and other inflammatory mediators. Additionally, this receptor is involved in some drug-induced allergic reactions, making it a potential target of medical interest in drug development and allergy research.

H_MRGPRX2 Gq Reporter CHO-K1 Cell Line is a clonal stable cell line constructed using lentiviral technology, constitutive expression of the MRGPRX2 gene, along with signal-dependent expression of a luciferase reporter gene. When Cortistatin-14 binds to the MRGPRX2, it activates the downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to MRGPRX2.
MRGPRX2 (Mas-related G protein-coupled receptor member X2) is a G protein-coupled receptor (GPCR) primarily expressed in mast cells and certain neural tissues. The MRGPRX2 receptor is involved in various physiological and pathological processes, including pain transmission, immune responses, and inflammatory reactions. It can recognize and bind to a variety of ligands, including cyclic peptides and pro-inflammatory molecules. MRGPRX2 is associated with certain allergic diseases, such as chronic urticaria and anaphylactic shock, as its expression in mast cells can trigger the release of histamine and other inflammatory mediators. Additionally, this receptor is involved in some drug-induced allergic reactions, making it a potential target of medical interest in drug development and allergy research.

H_MRGPRX2 Gq Reporter CHO-K1 Cell Line is a clonal stable cell line constructed using lentiviral technology, constitutive expression of the MRGPRX2 gene, along with signal-dependent expression of a luciferase reporter gene. When Cortistatin-14 binds to the MRGPRX2, it activates the downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to MRGPRX2.
Data Display
Signaling Pathway
Response to Cortistatin-14. The H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) at a concentration of 1E4 cells/well (96-well format) was stimulated with serial dilutions of Cortistatin-14 (MCE/HY-P1932) in assay buffer (F12K + 1% FBS + 1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [25.6]. Data are shown by drug mass concentration.
Response to Compound 48/80. The H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) at a concentration of 1E4 cells/well (96-well format) was stimulated with serial dilutions of Compound 48/80 (MCE/HY-115768) in assay buffer (F12K + 1% FBS + 1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [23.9]. Data are shown by drug mass concentration.
Response to Substance P. The H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) at a concentration of 1E4 cells/well (96-well format) was stimulated with serial dilutions of Substance P (MCE/HY-P0201) in assay buffer (F12K + 1% FBS + 1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [8.7]. Data are shown by drug molar concentration.
Applications
Inhibition of Cortistatin-14 induced reporter activity by MrgprX2 antagonist-1.Serial dilutions of the MrgprX2 antagonist-1 (MCE/HY-145191) were incubated with 1E4 cells/well of the H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) in a 96-well plate for 1 hour in assay buffer (F12K + 1% FBS + 1% P.S). Subsequently, the Cortistatin-14 (MCE/HY-P1932) at a density of 0.2 μg/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech) (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis. Data are shown by drug molar concentration.
Expression
H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) was determined by flow cytometry using APC anti-human MRGX2 Antibody (Biolegend/359006).
Specifications
Cat. No GM-C44540
Product H_MRGPRX2 Gq Reporter CHO-K1 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C44540
Product H_MRGPRX2 Gq Reporter CHO-K1 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Materials
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Cortistatin-14 MCE/HY-P1932
Compound 48/80 MCE/HY-115768
Substance P MCE/HY-P0201
MrgprX2 antagonist-1 MCE/HY-145191
APC anti-human MRGX2 Antibody Biolegend/359006
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Cortistatin-14 MCE/HY-P1932
Compound 48/80 MCE/HY-115768
Substance P MCE/HY-P0201
MrgprX2 antagonist-1 MCE/HY-145191
APC anti-human MRGX2 Antibody Biolegend/359006
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Related products
OX40:OX40L
H_OX40 Reporter Cell Line H_OX40 Reporter DDX35TM Cell Line Cynomolgus_OX40L CHO-K1 Cell Line
H_OX40 CHO-K1 Cell Line H_OX40L CHO-K1 Cell Line H_OX40L HEK-293 Cell Line
Mouse_OX40L CHO-K1 Cell Line
Anti-H_OX40 hIgG2 Antibody(Ivuxolimab) Anti-OX40L hIgG1 Reference Antibody(Oxebio) Anti-OX40L hIgG4 Antibody(Amlitelimab)
Anti-OX40L hIgG4 Reference Antibody(Amlbio)
Biotinylated Human OX40L Protein; His-Avi Tag Cynomolgus OX40 Protein; His Tag Cynomolgus OX40L Protein; His Tag
Cynomolgus OX40L Protein; mFc Tag Human OX40 Protein; His Tag Human OX40L Protein; His Tag
Human OX40L Protein; mFc Tag    
IL-4/IL-13
IL-4 Reporter Cell Line IL-4/IL-13 Reporter 293 Cell Line IL-4/IL-13 Reporter 293 DDX35TM Cell Line
Cynomolgus_IL4R CHO-K1 Cell Line H_IL4R CHO-K1 Cell Line H_IL4R CHO-K1 Cell Line (Low Expression)
H_IL4R HEK-293 Cell Line Mouse_IL4R CHO-K1 Cell Line
Anti-IL13 hIgG4 Reference Antibody (Lebribio) Anti-IL-4 hIgG1 Antibody (pascolizumab) Anti-IL-4R hIgG1 Antibody(12B5)
Anti-IL4R hIgG4 Antibody(Dupilumab) Anti-IL4R hIgG4 Reference Antibody (Dupbio) Anti-IL-4R×IL31 hIgG4 Reference Antibody (PRO2198)
Anti-Mouse IL13 mIgG2a Antibody (BAK209B11) Anti-Mouse IL-4RA mIgG1 Antibody
Biotinylated Human IL-4R alpha Protein; Avi-His Tag Cynomolgus IL-13 Protein; His Tag Cynomolgus IL-4 Protein; His Tag
Cynomolgus IL-4R alpha Protein; His Tag Human IL-13 Protein; His Tag Human IL-13RA1 Protein; His Tag
Human IL-4 Protein; His Tag Human IL-4R alpha Protein; hFc Tag Human IL-4R alpha Protein; His Tag
Human IL-4R alpha Protein; mFc Tag Mouse IL-13 Protein; His Tag Mouse IL-4R alpha Protein; His Tag
Rat IL-4R alpha Protein; His Tag    
IL-31
Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line H_IL-31 Reporter Cell Line H_IL-31 Reporter DDX35TM Cell Line
Cynomolgus_IL31RA CHO-K1 Cell Line H_IL31RA CHO-K1 Cell Line H_IL31RA HEK-293 Cell Line
H_IL-31RA OSMR Baf3 Cell Line H_IL-31RA OSMR CHO-K1 Cell Line
Anti-IL31 hIgG1 Antibody(mAb33) Anti-IL-31 hIgG4 Reference Antibody (BMS-981164) Anti-IL31RA hIgG1 Antibody(NA633)
Anti-IL31RA hIgG2 Antibody(Nemolizumab) Anti-IL31RA hIgG2 Reference Antibody (Nemobio) Anti-IL-4R×IL31 hIgG4 Reference Antibody (PRO2198)
Anti-OSMR hIgG4 Antibody(Vixarelimab) Anti-OSMR hIgG4 Reference Antibody (Vixabio)
Cynomolgus IL-31 Protein; His Tag Human IL-31 Protein; His Tag Human IL-31RA Protein; hFc Tag
c-Kit:SCF
H_c-Kit(CD117) GNNK(-) 293 Blockade Reporter Cell Line Cynomolgus_c-Kit(CD117) GNNK(-) CHO-K1 Cell Line H_c-Kit(CD117) GNNK(-) CHO-K1 Cell Line
H_c-Kit(CD117) GNNK(-) HEK-293 Cell Line H_c-Kit(CD117) GNNK(+) CHO-K1 Cell Line H_KITLG(SCF220) CHO-K1 Cell Line
H_KITLG(SCF248) CHO-K1 Cell Line
Anti-c-Kit(CD117) hIgG1 Antibody(barzolvolimab) Anti-c-Kit(CD117) hIgG1 Antibody(briquilimab) Anti-c-Kit(CD117) hIgG1 Reference Antibody (Bribio)
Anti-c-Kit(CD117) hIgG1 Reference Antibody(barbio) Anti-SCF248 hIgG4 Antibody(5H10)
Biotinylated Human c-Kit(CD117) Protein; His-Avi Tag Biotinylated Human SCF Protein; His-Avi Tag Cynomolgus c-Kit(CD117) Protein; His Tag
Human c-Kit(CD117) D4-D5 Protein; His Tag Human c-Kit(CD117) Protein; hFc Tag Human c-Kit(CD117) Protein; His Tag
Human SCF Protein; His Tag Human SCF Protein; mFc Tag  
MRGPRX2
H_MRGPRX2 Gqi5 Reporter CHO-K1 Cell Line Tango-H_MRGPRX2 CHO-K1 Cell Line Cynomolgus_MRGPRX2 CHO-K1 Cell Line
Cynomolgus_MRGPRX2 HEK-293 Cell Line Flag-Mouse_Mrgprb2 CHO-K1 Cell Line Flag-Rat_Mrgprb3 HEK-293 Cell Line
H_MRGPRX2 CHO-K1 Cell Line H_MRGPRX2 HEK-293 Cell Line H_MRGPRX2 HMC-1 Cell Line
H_MRGPRX2 RBL-2H3 Cell Line    
IGHE(FcεRIα)
FcεRIα Reporter RBL-2H3 Cell Line Membrane IgE(mIgE) HEK-293 Cell Line
Anti-FcεRI hIgG1 Antibody (1E7) Anti-IGHE hIgG1 Reference Antibody(Omalbio)
Biotinylated Human IgE D2-D4 Protein; His-Avi Tag Cynomolgus IgE D2-D4 Protein; His Tag Human FCER1A Protein; His Tag
Human FCER2(CD23) Protein; His Tag Human IgE D2-D4 Protein; His Tag  
H_MRGPRX2 Gq Reporter CHO-K1 Cell Line
Cat. No.
GM-C44540
Size
1 vial
Quote
Description
Data Display
Specifications
Materials
Cell Culture
Related products
Description
MRGPRX2 (Mas-related G protein-coupled receptor member X2) is a G protein-coupled receptor (GPCR) primarily expressed in mast cells and certain neural tissues. The MRGPRX2 receptor is involved in various physiological and pathological processes, including pain transmission, immune responses, and inflammatory reactions. It can recognize and bind to a variety of ligands, including cyclic peptides and pro-inflammatory molecules. MRGPRX2 is associated with certain allergic diseases, such as chronic urticaria and anaphylactic shock, as its expression in mast cells can trigger the release of histamine and other inflammatory mediators. Additionally, this receptor is involved in some drug-induced allergic reactions, making it a potential target of medical interest in drug development and allergy research.

H_MRGPRX2 Gq Reporter CHO-K1 Cell Line is a clonal stable cell line constructed using lentiviral technology, constitutive expression of the MRGPRX2 gene, along with signal-dependent expression of a luciferase reporter gene. When Cortistatin-14 binds to the MRGPRX2, it activates the downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to MRGPRX2.

MRGPRX2 (Mas-related G protein-coupled receptor member X2) is a G protein-coupled receptor (GPCR) primarily expressed in mast cells and certain neural tissues. The MRGPRX2 receptor is involved in various physiological and pathological processes, including pain transmission, immune responses, and inflammatory reactions. It can recognize and bind to a variety of ligands, including cyclic peptides and pro-inflammatory molecules. MRGPRX2 is associated with certain allergic diseases, such as chronic urticaria and anaphylactic shock, as its expression in mast cells can trigger the release of histamine and other inflammatory mediators. Additionally, this receptor is involved in some drug-induced allergic reactions, making it a potential target of medical interest in drug development and allergy research.

H_MRGPRX2 Gq Reporter CHO-K1 Cell Line is a clonal stable cell line constructed using lentiviral technology, constitutive expression of the MRGPRX2 gene, along with signal-dependent expression of a luciferase reporter gene. When Cortistatin-14 binds to the MRGPRX2, it activates the downstream signaling pathways, leading to the expression of luciferase. The luciferase activity measurement indicates the activation level of the signaling pathway and can thus be used to evaluate the in vitro effects of drugs related to MRGPRX2.

Data Display
Signaling Pathway
Response to Cortistatin-14. The H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) at a concentration of 1E4 cells/well (96-well format) was stimulated with serial dilutions of Cortistatin-14 (MCE/HY-P1932) in assay buffer (F12K + 1% FBS + 1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [25.6]. Data are shown by drug mass concentration.
Response to Compound 48/80. The H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) at a concentration of 1E4 cells/well (96-well format) was stimulated with serial dilutions of Compound 48/80 (MCE/HY-115768) in assay buffer (F12K + 1% FBS + 1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [23.9]. Data are shown by drug mass concentration.
Response to Substance P. The H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) at a concentration of 1E4 cells/well (96-well format) was stimulated with serial dilutions of Substance P (MCE/HY-P0201) in assay buffer (F12K + 1% FBS + 1% P.S) for 6 hours. The firefly luciferase activity was measured using the Luciferase Reporter Assay Kit (Genomeditech). The maximum induction fold was approximately [8.7]. Data are shown by drug molar concentration.
Applications
Inhibition of Cortistatin-14 induced reporter activity by MrgprX2 antagonist-1.Serial dilutions of the MrgprX2 antagonist-1 (MCE/HY-145191) were incubated with 1E4 cells/well of the H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) in a 96-well plate for 1 hour in assay buffer (F12K + 1% FBS + 1% P.S). Subsequently, the Cortistatin-14 (MCE/HY-P1932) at a density of 0.2 μg/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity was then measured using the Luciferase Reporter Assay Kit (Genomeditech) (left Y-axis, relative luminescence units), with inhibition percentages shown on the right Y-axis. Data are shown by drug molar concentration.
Expression
H_MRGPRX2 Gq Reporter CHO-K1 Cell Line (Cat. GM-C44540) was determined by flow cytometry using APC anti-human MRGX2 Antibody (Biolegend/359006).
Specifications
Cat. No GM-C44540
Product H_MRGPRX2 Gq Reporter CHO-K1 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C44540
Product H_MRGPRX2 Gq Reporter CHO-K1 Cell Line
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Materials
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Cortistatin-14 MCE/HY-P1932
Compound 48/80 MCE/HY-115768
Substance P MCE/HY-P0201
MrgprX2 antagonist-1 MCE/HY-145191
APC anti-human MRGX2 Antibody Biolegend/359006
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Blasticidin Genomeditech/GM-040404
Puromycin Genomeditech/GM-040401
Cortistatin-14 MCE/HY-P1932
Compound 48/80 MCE/HY-115768
Substance P MCE/HY-P0201
MrgprX2 antagonist-1 MCE/HY-145191
APC anti-human MRGX2 Antibody Biolegend/359006
GMOne-Step 2.0 Luciferase Reporter Gene Assay Kit Genomeditech/GM-040513
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Blasticidin+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Related products
OX40:OX40L
H_OX40 Reporter Cell Line H_OX40 Reporter DDX35TM Cell Line Cynomolgus_OX40L CHO-K1 Cell Line
H_OX40 CHO-K1 Cell Line H_OX40L CHO-K1 Cell Line H_OX40L HEK-293 Cell Line
Mouse_OX40L CHO-K1 Cell Line
Anti-H_OX40 hIgG2 Antibody(Ivuxolimab) Anti-OX40L hIgG1 Reference Antibody(Oxebio) Anti-OX40L hIgG4 Antibody(Amlitelimab)
Anti-OX40L hIgG4 Reference Antibody(Amlbio)
Biotinylated Human OX40L Protein; His-Avi Tag Cynomolgus OX40 Protein; His Tag Cynomolgus OX40L Protein; His Tag
Cynomolgus OX40L Protein; mFc Tag Human OX40 Protein; His Tag Human OX40L Protein; His Tag
Human OX40L Protein; mFc Tag    
IL-4/IL-13
IL-4 Reporter Cell Line IL-4/IL-13 Reporter 293 Cell Line IL-4/IL-13 Reporter 293 DDX35TM Cell Line
Cynomolgus_IL4R CHO-K1 Cell Line H_IL4R CHO-K1 Cell Line H_IL4R CHO-K1 Cell Line (Low Expression)
H_IL4R HEK-293 Cell Line Mouse_IL4R CHO-K1 Cell Line
Anti-IL13 hIgG4 Reference Antibody (Lebribio) Anti-IL-4 hIgG1 Antibody (pascolizumab) Anti-IL-4R hIgG1 Antibody(12B5)
Anti-IL4R hIgG4 Antibody(Dupilumab) Anti-IL4R hIgG4 Reference Antibody (Dupbio) Anti-IL-4R×IL31 hIgG4 Reference Antibody (PRO2198)
Anti-Mouse IL13 mIgG2a Antibody (BAK209B11) Anti-Mouse IL-4RA mIgG1 Antibody
Biotinylated Human IL-4R alpha Protein; Avi-His Tag Cynomolgus IL-13 Protein; His Tag Cynomolgus IL-4 Protein; His Tag
Cynomolgus IL-4R alpha Protein; His Tag Human IL-13 Protein; His Tag Human IL-13RA1 Protein; His Tag
Human IL-4 Protein; His Tag Human IL-4R alpha Protein; hFc Tag Human IL-4R alpha Protein; His Tag
Human IL-4R alpha Protein; mFc Tag Mouse IL-13 Protein; His Tag Mouse IL-4R alpha Protein; His Tag
Rat IL-4R alpha Protein; His Tag    
IL-31
Cynomolgus_IL-31RA OSMR Reporter Baf3 Cell Line H_IL-31 Reporter Cell Line H_IL-31 Reporter DDX35TM Cell Line
Cynomolgus_IL31RA CHO-K1 Cell Line H_IL31RA CHO-K1 Cell Line H_IL31RA HEK-293 Cell Line
H_IL-31RA OSMR Baf3 Cell Line H_IL-31RA OSMR CHO-K1 Cell Line
Anti-IL31 hIgG1 Antibody(mAb33) Anti-IL-31 hIgG4 Reference Antibody (BMS-981164) Anti-IL31RA hIgG1 Antibody(NA633)
Anti-IL31RA hIgG2 Antibody(Nemolizumab) Anti-IL31RA hIgG2 Reference Antibody (Nemobio) Anti-IL-4R×IL31 hIgG4 Reference Antibody (PRO2198)
Anti-OSMR hIgG4 Antibody(Vixarelimab) Anti-OSMR hIgG4 Reference Antibody (Vixabio)
Cynomolgus IL-31 Protein; His Tag Human IL-31 Protein; His Tag Human IL-31RA Protein; hFc Tag
c-Kit:SCF
H_c-Kit(CD117) GNNK(-) 293 Blockade Reporter Cell Line Cynomolgus_c-Kit(CD117) GNNK(-) CHO-K1 Cell Line H_c-Kit(CD117) GNNK(-) CHO-K1 Cell Line
H_c-Kit(CD117) GNNK(-) HEK-293 Cell Line H_c-Kit(CD117) GNNK(+) CHO-K1 Cell Line H_KITLG(SCF220) CHO-K1 Cell Line
H_KITLG(SCF248) CHO-K1 Cell Line
Anti-c-Kit(CD117) hIgG1 Antibody(barzolvolimab) Anti-c-Kit(CD117) hIgG1 Antibody(briquilimab) Anti-c-Kit(CD117) hIgG1 Reference Antibody (Bribio)
Anti-c-Kit(CD117) hIgG1 Reference Antibody(barbio) Anti-SCF248 hIgG4 Antibody(5H10)
Biotinylated Human c-Kit(CD117) Protein; His-Avi Tag Biotinylated Human SCF Protein; His-Avi Tag Cynomolgus c-Kit(CD117) Protein; His Tag
Human c-Kit(CD117) D4-D5 Protein; His Tag Human c-Kit(CD117) Protein; hFc Tag Human c-Kit(CD117) Protein; His Tag
Human SCF Protein; His Tag Human SCF Protein; mFc Tag  
MRGPRX2
H_MRGPRX2 Gqi5 Reporter CHO-K1 Cell Line Tango-H_MRGPRX2 CHO-K1 Cell Line Cynomolgus_MRGPRX2 CHO-K1 Cell Line
Cynomolgus_MRGPRX2 HEK-293 Cell Line Flag-Mouse_Mrgprb2 CHO-K1 Cell Line Flag-Rat_Mrgprb3 HEK-293 Cell Line
H_MRGPRX2 CHO-K1 Cell Line H_MRGPRX2 HEK-293 Cell Line H_MRGPRX2 HMC-1 Cell Line
H_MRGPRX2 RBL-2H3 Cell Line    
IGHE(FcεRIα)
FcεRIα Reporter RBL-2H3 Cell Line Membrane IgE(mIgE) HEK-293 Cell Line
Anti-FcεRI hIgG1 Antibody (1E7) Anti-IGHE hIgG1 Reference Antibody(Omalbio)
Biotinylated Human IgE D2-D4 Protein; His-Avi Tag Cynomolgus IgE D2-D4 Protein; His Tag Human FCER1A Protein; His Tag
Human FCER2(CD23) Protein; His Tag Human IgE D2-D4 Protein; His Tag  
Message consultation
reset
submit
Message
Message consultation
reset
submit